Introduction
Free radicals and other reactive oxygen species (ROS), such as superoxide anion, hydroxyl radical and hydrogen peroxide, are an entire class of highly reactive molecules derived from the normal metabolism of oxygen or from exogenous factors and agents (Halliwell and Gutteridge, 1990 ). ROS are not only strongly associated with lipid peroxidation resulting in deterioration of food materials, but are also involved in the development of pathology of numerous diseases, including cancer (Panayiotidis, 2008) .
Cancer is the second largest single cause of death claiming over six million lives every year worldwide. It is well established that natural products are an excellent source of chemical structures with a wide variety of biological activities, including anticancer properties (Cragg and Newman, 2005) . This has opened up new fi elds of investigation of potential antitumour compounds, some of which are already widely used in cancer chemotherapy (Arcamone et al., 1980) . Cytotoxic screening models provide important preliminary data to select plant extracts and natural products with potential anticancer properties.
Ailanthus excelsa is a deciduous tree from the Simaroubaceae family and widely distributed in Asia and North Australia. Its native origin is China and it is known as "tree of heaven" (Adamik and Brauns, 1957) . In traditional medicine A. excelsa is used to cure wounds and skin eruption, and in the indigenous system of medicine it is used in febrifuge, bronchitis, asthma and in conditions of diarrhea and dysentery (British Pharmacopoeia, 1988 The present study aimed to investigate the chemical composition, and the antioxidant and antiproliferative activities of Ailanthus excelsa, a plant used in Egyptian traditional medicine. Chromatographic separation of a methanol extract of A. excelsa leaves yielded four fl avones, namely apigenin (1), apigenin 7-O-β-glucoside (2), luteolin (3), and luteolin 7-O-β-glucoside (4), and seven fl avonols, namely kaempferol (5), kaempferol 3-O-α-arabinoside (6), kaempferol 3-O-β-galactoside (7), quercetin (8), quercetin 3-O-α-arabinoside (9), quercetin 3-O-β-galactoside (10), and quercetin 3-O-rutinoside (11). The A. excelsa extract tested in different in vitro systems (DPPH and FRAP assays) showed signifi cant antioxidant activity. The potential antiproliferative activity of the A. excelsa extract and isolated fl avonoids against fi ve human cancer cell lines such as ACHN, COR-L23, A375, C32, and A549 was investigated in vitro by the SRB assay in comparison with one normal cell line, 142BR. The extract exhibited the highest inhibitory activity against C32 cells with an IC 50 value of 36.5 μg ml -1 . Interesting activity against COR-L23 was found with 10 (IC 50 value of 3.2 μg ml -1 ). Compounds 1 and 3 inhibited cell growth in both amelanotic melanoma and malignant melanoma cells.
celsa have demonstrated the presence of quassinoids, fl avonoids, alkaloids, terpenoids, and proteins (Ogura et al., 1977; Loizzo et al., 2007; Joshi et al., 2003a; Sherman et al., 1980; Nag and Matai, 1994) . A. excelsa extracts and some of its isolated compounds have demonstrated medicinal properties such as signifi cant antileukemic, antibacterial, antifungal, and antifertility activities (Ogura et al., 1977; Dhanasekaran et al., 1993; Shrimali et al., 2001; Joshi et al., 2003b) . As part of a screening program searching for natural products with anticancer properties, we have conducted an in vitro screening to evaluate the antioxidant and antiproliferative activity of the methanol extract and fl avonoids isolated from the leaves of Ailanthus excelsa.
Material and Methods

General experimental procedures
Nuclear magnetic resonance (NMR) experiments were performed using a Bruker Avance 300 MHz spectrometer (solvent CD 3 OD). The signals in the 1 H and 13 C NMR spectra were assigned unambiguously using 2D NMR techniques. Mass spectra were performed using an electrospray ionization mass spectrometer ZAB2-SEQ. Infrared spectra were recorded on a Perkin-Elmer FT 1600 spectrometer. UV spectra were recorded on a Beckman DU 640 apparatus. TLC analyses were carried out on silica gel 60 F 254 precoated plates (VWR International, Milan, Italy). Chemicals and reagents used for the study of antioxidant and cytotoxic activities were purchased from SigmaAldrich Co. (Milan, Italy) while other chemicals, solvents and reagents used in chromatography were purchased from Merck (Cairo, Egypt).
Plant material
A. excelsa (Roxb.) leaves were collected from Zoo Garden, Giza, Egypt. The plant material was identifi ed by Dr. Kamal El-Batanony, Professor of Taxonomy and Botany, Faculty of Science, Cairo University, Egypt. A voucher specimen was deposited in the NRC herbarium.
Extraction and isolation
Powdered air-dried leaves of A. excelsa (1 kg) were extracted with methanol (70%) in a Soxhlet apparatus at 50 °C. The extract was concentrated under reduced pressure to dryness to give 260 g (yield 26%). The crude extract was dissolved in 500 ml of distilled water and extracted with n-hexane. The residue (215 g) was subjected to silica gel column chromatography and eluted with n-hexane/methylene chloride/ethyl acetate/methanol using gradually increasing polarity of solvents. 130 fractions were collected. Fractions showing similar TLC profi les were pooled to provide combined fractions. The fractions were further purifi ed by Sephadex LH-20 column chromatography to afford eleven pure compounds, 1 -11.
DPPH (2,2-diphenyl-1-picrylhydrazyl) assay
The radical scavenging capacity was determined according to the technique reported by Loizzo et al. (2009a) . Aliquots of 1.5 ml of 0.25 mM DPPH solution in ethanol and 1.5 ml of A. excelsa MeOH extract at different concentrations were mixed. The mixture was shaken vigorously and allowed to reach a steady state at room temperature within 30 min. Decolourization of DPPH was determined by measuring the absorbance at λ = 517 nm with a Varian spectrophotometer. The DPPH radicals' scavenging activity was calculated according to the following equation: scavenging activity = [(A 0 -A 1 /A 0 ) · 100], where A 0 is the absorbance of the control (blank, without extract) and A 1 is the absorbance in the presence of the extract.
Ferric reducing ability power (FRAP) assay
The FRAP method measures the absorbance change that appears when the Fe 3+ -TPTZ (2,4,6-tripyridyl-s-triazine) complex is reduced to the Fe 2+ -TPTZ form in the presence of antioxidant compounds. An intense blue colour, with absorbance maximum at λ = 595 nm, develops (Benzie and Strains, 1996) . Briefl y, the FRAP reagent contained 2.5 ml of 10 mM TPTZ solution in 40 mM HCl plus 2.5 ml of 20 mM FeCl 3 , and 25 ml of 0.3 M acetate buffer (pH 3.6) freshly prepared. A. excelsa (0.2 ml) was mixed with 1.8 ml of FRAP reagent, and the absorbance of the reaction mixture was measured at λ = 595 nm. Ethanol solutions of known Fe 2+ concentration, in the range of 50 -500 μM FeSO 4 , were used for obtaining the calibration curve. The FRAP value represents the ratio between the slope of the linear plot for reducing Fe 3+ -TPTZ reagent by A. excelsa extract compared to the slope of the plot for FeSO 4 . , and ACHN cells were cultured in RPMI 1640 medium, while 142BR, A549, and A375 cells were cultured in DMEM. Both media were supplemented with 10% foetal bovine serum, 1% L-glutamine, and 1% penicillin/streptomycin. The cell lines were maintained at 37 °C in a 5% CO 2 atmosphere with 95% humidity.
Cell culture and in vitro cytotoxicity assay
The protein-staining SRB assay was used for measuring of the cell proliferation (Loizzo et al., 2005) . Briefl y, cells were placed in 96-well plates in the range 5 · 10 4 to 15 · 10 4 cells, to ensure exponential growth throughout the experimental period and to ensure a linear relationship between absorbance at λ = 490 nm and cell number, and incubated to allow for cell attachment. After 24 h the cells were treated with serial dilutions of the A. excelsa methanol extract and isolated fl avonoids. Each sample was initially dissolved in DMSO and further diluted in medium to produce different concentrations. 100 μl well -1 of each dilution was added to the plates in six replicates. The fi nal mixture used for treating the cells contained not more than 0.5% of the solvent (DMSO), the same as in the solvent-control wells. After 48 h of exposure 100 μl of ice-cold 40% trichloroacetic acid (TCA) were added to each well, left for 1 h at 4 °C, and washed with distilled water. The TCA-fi xed cells were stained for 30 min with 50 μl of 0.4% (w/v) SRB in 1% acetic acid. The plates were washed with 1% acetic acid and airdried overnight. For reading plate, the bound dye was solubilized with 100 μl of 10 mM Tris [tris(hydroxymethyl)aminomethane]. The absorbance of each well was read on a Molecular Devices SpectraMax Plus Plate Reader (Molecular Devices, CELBIO, Milan, Italy) at λ = 490 nm. Cell survival was measured as the percentage absorbance compared to the untreated control. Vinblastine sulfate was used as positive control. The antiproliferative activity of the A. excelsa extract and isolated fl avonoids was expressed in terms of their IC 50 values.
Statistical analysis
All experiments were carried out in triplicate. Data were expressed as mean ± S.D. Differences were evaluated by one-way analysis of variance (ANOVA) test completed by Dunnett's test. Differences were considered signifi cant at **p < 0.01. The 50% inhibitory concentration (IC 50 ) was calculated by a nonlinear regression curve with the use of Prism Graphpad Prism version 4.0 for Windows [GraphPad Software, San Diego, CA, USA (www.graphpad.com)]. The dose-response curve was obtained by plotting the percentage of inhibition versus the concentrations.
Results and Discussion
The methanol extract of A. excelsa leaves was chromatographed on a silica gel column followed by successive separation on Sephadex LH-20 affording eleven pure known fl avonoids identifi ed as four fl avones, namely apigenin (1), apigenin 7-O-β-glucoside (2), luteolin (3), and luteolin 7-O-β-glucoside (4), and seven fl avonols, namely kaempferol (5), kaempferol 3-O-α-arabinoside (6), kaempferol 3-O-β-galactoside (7), quercetin (8), quercetin 3-O-α-arabinoside (9), quercetin 3-O-β-galactoside (10), and quercetin 3-O-rutinoside (11) (Fig. 1) . Compounds 2, 5, 8, 10, 11 were isolated here for the fi rst time from A. excelsa. All the structures were determined from UV, MS and NMR spectral data, which were identical with those previously reported (Nakasugi and Komai, 1998; Sanbongi et al., 1998; Foo et al., 2000; Flamini et al., 2001) .
The A. excelsa antioxidant activity was screened employing different established in vitro systems. A rapid, simple and inexpensive method to measure the antioxidant capacity involves the use of the free DPPH radical. DPPH is widely used to test the ability of compounds to act as free radical scavengers or hydrogen donors, and to evaluate the antioxidant activity. It has also been used to quantify antioxidants in complex biological systems in recent years. The IC 50 value for DPPH scavenging by an A. excelsa extract is 85.71 μg ml (Benzie and Strains, 1996) . Using this assay, the FRAP value of the extract was found to be 1.2 compared to ascorbic acid (0.9) ( Table  I ). Some researchers reported that phenolic compounds exhibited redox properties (i.e. acted as reducing agents, hydrogen donators, and singlet oxygen quenchers). The redox potential of phenolic phytochemicals plays a crucial role in determining the antioxidant properties (Rice-Evans et al., 1997) .
The antiproliferative activity of the A. excelsa extract and isolated fl avonoids on inhibition of cell proliferation in the human cancer cell lines COR-L23, C32, ACHN, A375 and A549 was evaluated in comparison with one normal cell line, 142BR. A dose-response relationship was observed for all tested samples. The IC 50 values are reported in Table II. The A. excelsa extract exhibited the highest inhibitory activity against C32 cells with an IC 50 value of 36.5 μg ml -1 . Among the identifi ed fl avonoids quercetin (8) evidenced strong antiproliferative activity against amelanotic melanoma, malignant melanoma and lung large cell carcinoma cells with IC 50 values ranging from 0.3 to 0.7 μg ml -1 , respectively, as previously reported (Loizzo et al., 2009b) . . An interesting activity was found with apigenin (1); it was applied to both amelanotic melanoma and malignant melanoma cell cultures with IC 50 values of 4.7 and 5.5 μg ml -1 , respectively. Both, quercetin 3-O-β-galactoside (10) and quercetin 3-O-α-arabinoside (9) are able to inhibit lung large cell carcinoma proliferation with IC 50 values of 3.2 and 7.5 μg ml -1 , respectively. Several studies have been done on fl avonoids' antiproliferative effects against human ovarian, leukemic, intestinal, lung, breast and bladder cancer cells (Scambia et al., 1994; Agullo et al., 1997; Narayanan et al., 1999; Uddin and Choudhry, 1995) .
The ability of fl avonoids to exert specifi c cytotoxic activity towards cancer cells has generated large interest in developing fl avonoid-based cytostatics for anticancer therapy (Galati and O'Brien, 2004) . There are several suggested mechanism by which fl avonoids could exert anticancer activity including proteasome inhibition (Chen et al., 2005) , inhibition of fatty acid synthesis (Brusselmans et al., 2005) , topoisomerase inhibition (Constantinou et al., 1995) , inhibition of phosphatidylinositol 3-kinase (Agullo et al., 1997) , induction of cell cycle arrest (Lepley et al., 1996) , induction of p53 (Plaumann et al., 1996) or enhanced expression of c-fos and c-myc proto-oncogenes (Chen et al., 1998) .
Plants are an excellent source of chemical compounds with a wide variety of biological activities, including anticancer properties. Fundamental phytochemical investigations should be encouraged, especially in view of the urgent need to discover new bioactive molecules with greater effi cacy and less side effects than existing drugs. The A. excelsa extract and isolated fl avonoids evidenced significant antioxidant and antiproliferative activities. An increasing number of research studies have established a positive correlation between the consumption of fl avonoids and reduced risk of cancer. This is supported by a multitude of in vitro and in vivo studies, which show that fl avonoids may inhibit various stages in the carcinogenesis process, namely tumour initiation, promotion, and progression. Based on this studies many mechanisms of action may be involved. These include carcinogen inactivation, antiproliferation, cell cy- Vinblastine ACHN >100 20.7 ± 2.1** 38.6 ± 2.1** 26.6 ± 3.3** 34.2 ± 0.9** 42.8 ± 2.9** 13.6 ± 0.06** 34.9 ± 0.06** 12.6 ± 1.1** >50 11.5 ± 0.35** 35.5 ± 0.35** 22.7 ± 1.6 COR-L23 95.2 ± 3.1** 8.9 ± 0.012** 36.6 ± 4.8** 5.3 ± 0.07** 13.5 ± 0.04** 2.7 ± 0.08** 36.1 ± 0.09** 44.9 ± 0.11°0.3 ± 0.002** 7.5 ± 0.07** 3.2 ± 0.02** 14.2 ± 0.02** 45.5 ± 0.7 A375 78.4 ± 3.7** 5.5 ± 0.042°42.2 ± 2.5** 5.2 ± 0.05°14.0 ± 0.09** 36.8 ± 2.3** cle arrest, induction of apoptosis and differentiation, inhibition of angiogenesis, antioxidation, and reversal of multidrug resistance or a combination of these mechanisms. Furthermore, the intriguing results from laboratory and epidemiological studies have stimulated the development of fl avonoids in human clinical trials.
